How useful is molecular profiling when enrolling glioma patients in early phase clinical trials?

Reporting results from a new study at EANO 2019, researchers from centers in France suggest that using molecular profiling as a guide to patient enrollment is not only feasible, but also offers potential benefits to study participants in terms of clinical outcomes.